missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ I-BET 762
Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.
154.00 CHF - 517.00 CHF
Spezifikation
Chemischer Name oder Material | (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide |
---|---|
CAS | 1260907-17-2 |
Ziel | Bromodomain Inhibitors |
Summenformel | C22H22ClN5O2 |
Reinheit | 0.98 |
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
---|---|---|---|---|---|---|---|---|---|
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
18094322
|
Tocris Bioscience™
6521/25 |
25 mg |
517.00 CHF
25 Milligramm |
Verfügbar ab: 03-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
18054232
|
Tocris Bioscience™
6521/5 |
5 mg |
154.00 CHF
5 Milligramm |
Verfügbar ab: 03-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
Beschreibung
I-BET 762 is a potent and high affinity BET bromodomain inhibitor (IC50 = 32.5 - 42.5 nM; Kd = 50.5 - 61.3 nM). Inhibits myeloma cell proliferation. Attenuates transcription of oncogenic MYC and suppresses key inflammatory genes. Exhibits efficacy in a range of oncology and immunoinflammatory models. Displays antiproliferative effect in vitro and in vivo. Orally bioavailable.Spezifikation
(4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide | |
Bromodomain Inhibitors | |
0.98 |
1260907-17-2 | |
C22H22ClN5O2 |
Sicherheit und Handhabung
Recommended Storage : Lagerung bei -20 °C